For: | Katoch S, Sharma V, Patial V. Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios. World J Gastroenterol 2022; 28(28): 3535-3554 [PMID: 36161051 DOI: 10.3748/wjg.v28.i28.3535] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i28/3535.htm |
Number | Citing Articles |
1 |
Zhenshan Zhang, Leilei Wu, Juan Li, Jiayan Chen, Qi Yu, Hui Yao, Yaping Xu, Liang Liu. Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular Carcinoma. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03790-0
|
2 |
Xiyu Liu, Xiaohong Wang. The prognosis of patients with co-morbid diabetes and hepatitis B and strategies for improving outcome. The American Journal of the Medical Sciences 2024; doi: 10.1016/j.amjms.2024.12.011
|
3 |
Han Zhang, Zexuan Zhu, Hui Li, Shan He. Network Biomarker Detection From Gene Co-Expression Network Using Gaussian Mixture Model Clustering. IEEE/ACM Transactions on Computational Biology and Bioinformatics 2023; 20(6): 3523 doi: 10.1109/TCBB.2023.3297388
|
4 |
Nicholas Dale D. Talubo, Po-Wei Tsai, Lemmuel L. Tayo. Comprehensive RNA-Seq Gene Co-Expression Analysis Reveals Consistent Molecular Pathways in Hepatocellular Carcinoma across Diverse Risk Factors. Biology 2024; 13(10): 765 doi: 10.3390/biology13100765
|
5 |
Ke Zhan, Xin Yang, Shuang Li, Yang Bai. Correlation of endoplasmic reticulum stress patterns with the immune microenvironment in hepatocellular carcinoma: a prognostic signature analysis. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1270774
|
6 |
Yi Shang, Takamitsu Morioka, Kazuhiro Daino, Takafumi Nakayama, Mayumi Nishimura, Shizuko Kakinuma. Ionizing radiation promotes, whereas calorie restriction suppresses, NASH and hepatocellular carcinoma in mice. International Journal of Cancer 2023; 153(8): 1529 doi: 10.1002/ijc.34651
|
7 |
Donika Ivanova, Severina Semkova, Boncho Grigorov, Milena Tzanova, Ana Georgieva, Dancho Danchev, Biliana Nikolova, Zvezdelina Yaneva. The General Principle of the Warburg Effect as a Possible Approach for Cancer Immunotherapy: The Regulatory Effect of Plant Extracts Could Change the Game. Molecules 2025; 30(2): 393 doi: 10.3390/molecules30020393
|
8 |
A. Khoo, M. Boyer, Z. Jafri, T. Makeham, T. Pham, L. M. Khachigian, P. Floros, E. Dowling, K. Fedder, D. Shonka, J. Garneau, C. H. O’Meara. Human Papilloma Virus Positive Oropharyngeal Squamous Cell Carcinoma and the Immune System: Pathogenesis, Immunotherapy and Future Perspectives. International Journal of Molecular Sciences 2024; 25(5): 2798 doi: 10.3390/ijms25052798
|
9 |
Madalina Andreea Robea, Ioana-Miruna Balmus, Irina Girleanu, Laura Huiban, Cristina Muzica, Alin Ciobica, Carol Stanciu, Carmen Diana Cimpoesu, Anca Trifan. Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease—Oxidative Stress and Inflammation Relevance. Medicina 2023; 59(9): 1614 doi: 10.3390/medicina59091614
|
10 |
Ui-Hyun Park, HyeSook Youn, Eun-Joo Kim, Soo-Jong Um. Shikonin Binds and Represses PPARγ Activity by Releasing Coactivators and Modulating Histone Methylation Codes. Nutrients 2023; 15(7): 1797 doi: 10.3390/nu15071797
|
11 |
Howard D Lee, Li-Yun Yuan. Nano-revolution in hepatocellular carcinoma: A multidisciplinary odyssey - Are we there yet?. World Journal of Hepatology 2024; 16(5): 684-687 doi: 10.4254/wjh.v16.i5.684
|
12 |
Vinesh Sharma, Vikram Patial. Peroxisome proliferator-activated receptor gamma and its natural agonists in the treatment of kidney diseases. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.991059
|
13 |
Fereshteh Asgharzadeh, Arghavan Memarzia, Vida Alikhani, Sima Beigoli, Mohammad Hossein Boskabady. Peroxisome proliferator-activated receptors: Key regulators of tumor progression and growth. Translational Oncology 2024; 47: 102039 doi: 10.1016/j.tranon.2024.102039
|
14 |
Stephanie Talamantes, Michela Lisjak, Eduardo H. Gilglioni, Camilo J. Llamoza-Torres, Bruno Ramos-Molina, Esteban N. Gurzov. Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma. JHEP Reports 2023; 5(9): 100811 doi: 10.1016/j.jhepr.2023.100811
|
15 |
Katarzyna Walczak, Agnieszka Gerkowicz, Dorota Krasowska. PPARs and the Kynurenine Pathway in Melanoma—Potential Biological Interactions. International Journal of Molecular Sciences 2023; 24(4): 3114 doi: 10.3390/ijms24043114
|
16 |
Lu shan, Yijun Chen, Guo An, Xiaoyu Tao, Chuanqi Qiao, Meilin Chen, Jiaqi Li, Ruichao Lin, Jiarui Wu, Chongjun Zhao. Polyphyllin I exerts anti-hepatocellular carcinoma activity by targeting ZBTB16 to activate the PPARγ/RXRα signaling pathway. Chinese Medicine 2024; 19(1) doi: 10.1186/s13020-024-00984-0
|
17 |
Xuguang Yang, Bo Deng, Weiwei Zhao, Yangyang Guo, Yaqi Wan, Zhihao Wu, Sheng Su, Jingyan Gu, Xiaoqian Hu, Wenxue Feng, Chencheng Hu, Jia Li, Yanyong Xu, Xiaowu Huang, Yuli Lin. FABP5+ lipid-loaded macrophages process tumour-derived unsaturated fatty acid signal to suppress T-cell antitumour immunity. Journal of Hepatology 2024; doi: 10.1016/j.jhep.2024.09.029
|
18 |
Maryam Golmohammadi, Mehraveh Sadeghi Ivraghi, Ekhlas Khammas Hasan, Huldani Huldani, Mohammad Yasin Zamanian, Shiva Rouzbahani, Yasser Fakri Mustafa, Shaker Shanawa Al-Hasnawi, Adeeb Abdulally Abdulhussien Alazbjee, Faranak Khalajimoqim, Fattaneh Khalaj. Protective effects of pioglitazone in renal ischemia–reperfusion injury (RIRI): focus on oxidative stress and inflammation. Clinical and Experimental Nephrology 2024; 28(10): 955 doi: 10.1007/s10157-024-02525-3
|
19 |
Ephraim E Parent, Amy M Fowler. Nuclear Receptor Imaging In Vivo—Clinical and Research Advances. Journal of the Endocrine Society 2023; 7(3) doi: 10.1210/jendso/bvac197
|
20 |
Tyrosinase-related Protein 1 Gene Knockout by CRISPR/Cas9 System Induces Apoptosis in Human Fibrosarcoma Cells. Applied Biochemistry and Microbiology 2025; doi: 10.1134/S0003683824604840
|